EXPLANATORY NOTE TO THIS EXHIBITLoan Agreement • January 6th, 2011 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances • Massachusetts
The Company’s representations and warranties included in this Loan Agreement were made to each of the lenders hereunder. These representations and warranties were made as of specific dates, only for purposes of this Loan Agreement and for the benefit of the parties thereto. These representations and warranties were subject to important exceptions and limitations agreed upon by the parties, made for the purposes of allocating contractual risk between the parties rather than establishing these matters as facts and were made subject to a contractual standard of materiality that may be different from the standard generally applicable under federal securities laws. This Loan Agreement is filed with this report only to provide investors with information regarding its terms and conditions, and not to provide any other factual information regarding the Company or its business. Moreover, information concerning the subject matter of the representations and warranties may have changed, and may co
EXPLANATORY NOTE TO THIS EXHIBITSecurity Agreement • January 6th, 2011 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances
This Pledge Supplement, dated as of [ ], is delivered pursuant to Section 4.1 of that certain security agreement (as amended, supplemented or otherwise modified from time to time, the “Security Agreement;” capitalized terms used but not otherwise defined herein shall have the meanings assigned to such terms in the Security Agreement), dated as of December 30, 2010, made by SERACARE LIFE SCIENCES, INC., a Delaware corporation (the “Borrower”), the other Grantors party thereto and Middlesex Savings Bank, as Secured Party (as such term is defined in the Security Agreement). The undersigned hereby agrees that this Pledge Supplement may be attached to the Security Agreement and that the Pledged Securities and/or Intercompany Notes listed on this Pledge Supplement shall be deemed to be and shall become part of the Pledged Collateral and shall secure all Secured Obligations.
